Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -14.24 | -23.37 |
| PEG Ratio (TTM) | -1.14 | -7.10 |
| P/S Ratio (TTM) | 16.94 | 44.34 |
| P/B Ratio (TTM) | 1.76 | 33.03 |
| P/FCF Ratio (TTM) | -17.87 | -7.73 |
| Price to 5YR AVG Earnings Ratio | -21.31 | -7.08 |
| Price to 5YR AVG FCF Ratio | -30.79 | -13.02 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.62% | -15.67% |
| ROE (TTM) | -12.15% | 27.44% |
| Net Profit Margin (TTM) | -118.83% | -627.99% |
| ROIC 5YR AVG | -13.96% | -4.84% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.06% | -66.79% | -78.36% |
| Revenue | -20.18% | 59,041.64% | 52,412.79% |
| Net Income | -6.81% | -91.01% | -93.76% |
| Cash Flow | -31.44% | -11.86% | -36.01% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 21.64 | 5.66 |
| Quick Ratio (TTM) | 21.64 | 5.44 |
| D/E Ratio (TTM) | 0.01 | 1.19 |
| Interest Coverage (TTM) | N/A | -5.92 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 6.38 | 13.21 |
| LTL to 5YR AVG FCF | -2.01 | 0.09 |
| Shares Outstanding Growth 5YR AVG | 10.82% | 39.51% |